316 related articles for article (PubMed ID: 35812139)
21. Development of the natural response of immunoglobulin secreting cells in the pig as a function of organ, age and housing.
Bianchi AT; Scholten JW; Moonen Leusen BH; Boersma WJ
Dev Comp Immunol; 1999 Sep; 23(6):511-20. PubMed ID: 10512461
[TBL] [Abstract][Full Text] [Related]
22. Application of an M-cell-targeting ligand for oral vaccination induces efficient systemic and mucosal immune responses against a viral antigen.
Kim SH; Jung DI; Yang IY; Jang SH; Kim J; Truong TT; Pham TV; Truong NU; Lee KY; Jang YS
Int Immunol; 2013 Nov; 25(11):623-32. PubMed ID: 23900425
[TBL] [Abstract][Full Text] [Related]
23. Regulation of macrophage and dendritic cell function by pathogens and through immunomodulation in the avian mucosa.
de Geus ED; Vervelde L
Dev Comp Immunol; 2013 Nov; 41(3):341-51. PubMed ID: 23542704
[TBL] [Abstract][Full Text] [Related]
24. Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways.
Brandtzaeg P
Am J Respir Crit Care Med; 2011 Jun; 183(12):1595-604. PubMed ID: 21471092
[TBL] [Abstract][Full Text] [Related]
25. In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry.
Van Der Lubben IM; Konings FA; Borchard G; Verhoef JC; Junginger HE
J Drug Target; 2001; 9(1):39-47. PubMed ID: 11378522
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobulins, Mucosal Immunity and Vaccination in Teleost Fish.
Yu Y; Wang Q; Huang Z; Ding L; Xu Z
Front Immunol; 2020; 11():567941. PubMed ID: 33123139
[TBL] [Abstract][Full Text] [Related]
27. M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis.
Corr SC; Gahan CC; Hill C
FEMS Immunol Med Microbiol; 2008 Jan; 52(1):2-12. PubMed ID: 18081850
[TBL] [Abstract][Full Text] [Related]
28. Tracking of an Oral
Mbongue JC; Alhoshani A; Rawson J; Garcia PA; Gonzalez N; Ferreri K; Kandeel F; Husseiny MI
Front Immunol; 2020; 11():712. PubMed ID: 32411136
[TBL] [Abstract][Full Text] [Related]
29. Delivery strategies to enhance oral vaccination against enteric infections.
Davitt CJ; Lavelle EC
Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
[TBL] [Abstract][Full Text] [Related]
30. Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches.
van der Lubben IM; Verhoef JC; van Aelst AC; Borchard G; Junginger HE
Biomaterials; 2001 Apr; 22(7):687-94. PubMed ID: 11246962
[TBL] [Abstract][Full Text] [Related]
31. Distinct roles for Peyer's patch B cells for induction of antigen-specific IgA antibody responses in mice administered oral recombinant Salmonella.
Hashizume-Takizawa T; Shibata N; Kurashima Y; Kiyono H; Kurita-Ochiai T; Fujihashi K
Int Immunol; 2019 Jul; 31(8):531-541. PubMed ID: 30868152
[TBL] [Abstract][Full Text] [Related]
32. Morphine inhibits mucosal antibody responses and TGF-beta mRNA in gut-associated lymphoid tissue following oral cholera toxin in mice.
Peng X; Cebra JJ; Adler MW; Meissler JJ; Cowan A; Feng P; Eisenstein TK
J Immunol; 2001 Oct; 167(7):3677-81. PubMed ID: 11564781
[TBL] [Abstract][Full Text] [Related]
33. Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells.
Suzuki H; Sekine S; Kataoka K; Pascual DW; Maddaloni M; Kobayashi R; Fujihashi K; Kozono H; McGhee JR; Fujihashi K
Gastroenterology; 2008 Sep; 135(3):917-25. PubMed ID: 18565333
[TBL] [Abstract][Full Text] [Related]
34. Mucosal Immune System and M Cell-targeting Strategies for Oral Mucosal Vaccination.
Kim SH; Lee KY; Jang YS
Immune Netw; 2012 Oct; 12(5):165-75. PubMed ID: 23213309
[TBL] [Abstract][Full Text] [Related]
35. Lack of antigen-specific immune responses in anti-IL-7 receptor alpha chain antibody-treated Peyer's patch-null mice following intestinal immunization with microencapsulated antigen.
Kunisawa J; Takahashi I; Okudaira A; Hiroi T; Katayama K; Ariyama T; Tsutsumi Y; Nakagawa S; Kiyono H; Mayumi T
Eur J Immunol; 2002 Aug; 32(8):2347-55. PubMed ID: 12209648
[TBL] [Abstract][Full Text] [Related]
36. Transport of artificial virus-like nanocarriers through intestinal monolayers via microfold cells.
Tong T; Qi Y; Bussiere LD; Wannemuehler M; Miller CL; Wang Q; Yu C
Nanoscale; 2020 Aug; 12(30):16339-16347. PubMed ID: 32725029
[TBL] [Abstract][Full Text] [Related]
37. Review article: Local and systemic regulation of mucosal immunity.
Mayer L
Aliment Pharmacol Ther; 1997 Dec; 11 Suppl 3():81-5; discussion 85-8. PubMed ID: 9467982
[TBL] [Abstract][Full Text] [Related]
38. Targeted Delivery of GP5 Antigen of PRRSV to M Cells Enhances the Antigen-Specific Systemic and Mucosal Immune Responses.
Du L; Yu Z; Pang F; Xu X; Mao A; Yuan W; He K; Li B
Front Cell Infect Microbiol; 2018; 8():7. PubMed ID: 29423381
[TBL] [Abstract][Full Text] [Related]
39. Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis.
Obata T; Goto Y; Kunisawa J; Sato S; Sakamoto M; Setoyama H; Matsuki T; Nonaka K; Shibata N; Gohda M; Kagiyama Y; Nochi T; Yuki Y; Fukuyama Y; Mukai A; Shinzaki S; Fujihashi K; Sasakawa C; Iijima H; Goto M; Umesaki Y; Benno Y; Kiyono H
Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7419-24. PubMed ID: 20360558
[TBL] [Abstract][Full Text] [Related]
40. NALT- versus Peyer's-patch-mediated mucosal immunity.
Kiyono H; Fukuyama S
Nat Rev Immunol; 2004 Sep; 4(9):699-710. PubMed ID: 15343369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
